Consensus CVS Health Corporation

Equities

CVS

US1266501006

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
59.6 ^USD	+6.35%		+7.31%	-24.52%

May. 30	JPMorgan Adjusts Price Target on CVS Health to $86 From $101	MT
May. 30	Baird Initiates CVS Health With Neutral Rating, $61 Price Target	MT

Evolution of the average Target Price on CVS Health Corporation

Price target over the last 5 years

History of analyst recommendation changes

6fbceac7b069ffc33a.0WqrLRndpl62Af0iwk5w0EvughVwBMCX1GaQ4MsyCbI.tSTnVXe262bfS4thqXcBtiasr3Y8d_LOgSDcob9cMf_oJfJCdJrUPf5wrA~db660cbee1c2ecc27fac465cfadab1d4

Analyst Recommendations on CVS Health Corporation

JPMorgan Adjusts Price Target on CVS Health to $86 From $101	May. 30	MT
Baird Initiates CVS Health With Neutral Rating, $61 Price Target	May. 30	MT
Wolfe Research Lowers CVS Health's Price Target to $64 From $70	May. 28	MT
Argus Research Adjusts Price Target on CVS Health to $80 From $100	May. 08	MT
ANALYST RECOMMENDATIONS : Walt Disney, Tractor Supply Company, KKR, Occidental Petroleum...	May. 08
ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins...	May. 07
Wells Fargo Adjusts CVS Health's Price Target to $60 From $76	May. 07	MT
TD Cowen Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $59 From $99	May. 07	MT
Ameriprise Downgrades CVS Health to Hold From Buy	May. 06	MT
ARC Independent Research Adjusts Price Target on CVS Health to $65 From $80	May. 03	MT
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	May. 03
HSBC Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $62 From $91	May. 03	MT
Cvs Health Insider Bought Shares Worth $500,294, According to a Recent SEC Filing	May. 02	MT
Deutsche Bank Adjusts Price Target on CVS Health to $64 From $77	May. 02	MT
Raymond James Adjusts Price Target on CVS Health to $65 From $85	May. 02	MT
Wolfe Adjusts Price Target on CVS Health to $70 From $88	May. 02	MT
Morgan Stanley Adjusts Price Target on CVS Health to $65 From $85	May. 02	MT
Jefferies Adjusts Price Target on CVS Health to $72 From $95	May. 02	MT
Barclays Adjusts Price Target on CVS Health to $63 From $78	May. 02	MT
Bernstein Adjusts Price Target on CVS Health to $62 From $93	May. 02	MT
Mizuho Adjusts Price Target on CVS Health to $72 From $86	May. 02	MT
Truist Lowers CVS Health's PT to $66 From $90 After Below-Consensus Q1 Results, Reduced Guidance; Keeps Buy Rating	May. 02	MT
UBS Downgrades CVS Health to Neutral From Buy	May. 02	MT
Truist Cuts Price Target on CVS Health to $66 From $90, Cites 'Challenging' Q1, Keeps Buy Rating	May. 02	MT
RBC Cuts Price Target on CVS Health to $68 From $84 Amid Reduced Guidance, Keeps Outperform Rating	May. 02	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

59.6 USD

Average target price

70.17 USD

Spread / Average Target

+17.73%

High Price Target

93.31 USD

Spread / Highest target

+56.56%

Low Price Target

59 USD

Spread / Lowest Target

-1.01%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CVS Health Corporation

JPMorgan Chase
Baird
Wolfe Research
Argus
Wells Fargo Securities
TD Cowen
Ameriprise Financial
ARC Independent Research
HSBC
Deutsche Bank Securities
Raymond James
Morgan Stanley
Truist Securities
Jefferies & Co.
Barclays
Bernstein
Mizuho Securities
UBS
RBC Capital Markets
Evercore ISI
Piper Sandler
Cantor Fitzgerald
Leerink Partners
Edward Jones
DA Davidson
Goldman Sachs
BofA Securities
Credit Suisse
Loop Capital
Tigress Financial
BMO Capital
Seaport Global Securities
Guggenheim

Ratings for CVS Health Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar